WTA
BNTX icon

Washington Trust Advisors’s BioNTech BNTX Stock Holding History

Washington Trust Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-57
Closed -$4.55K – 668
2024
Q2 		$4.55K Hold
57
– – ﹤0.01% 575
2024
Q1 		$5.22K Hold
57
– – ﹤0.01% 567
2023
Q4 		$5.97K Buy
+57
New +$5.74K ﹤0.01% 548

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Washington Trust Advisors's BNTX Position: Q3 2024 in Review

Washington Trust Advisors sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 57 shares — an estimated $4.55K sold.

Washington Trust Advisors first reported a position in BNTX in Q4 2023 and held it in 3 quarters. The position peaked at $5.97K in Q4 2023. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Washington Trust Advisors reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Washington Trust Advisors sold 57 BioNTech shares in Q3 2024, an estimated $4.55K.
  • Washington Trust Advisors first reported a position in BioNTech in Q4 2023 and held it in 3 quarters.
  • Washington Trust Advisors's BioNTech position peaked at $5.97K in Q4 2023.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Washington Trust Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.